{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:25:24Z","timestamp":1790378724408,"version":"4.1.0"},"reference-count":215,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In alcohol-induced liver disease (ALD) and in non-alcoholic fatty liver disease (NAFLD), there are abnormal accumulations of fat in the liver. This phenomenon may be related to excessive alcohol consumption, as well as the combination of alcohol consumption and medications. There is an evolution from simple steatosis to steatohepatitis, fibrosis and cirrhosis leading to hepatocellular carcinoma (HCC). Hepatic pathology is very similar regarding non-alcoholic fatty liver disease (NAFLD) and ALD. Initially, there is lipid accumulation in parenchyma and progression to lobular inflammation. The morphological changes in the liver mitochondria, perivenular and perisinusoidal fibrosis, and hepatocellular ballooning, apoptosis and necrosis and accumulation of fibrosis may lead to the development of cirrhosis and HCC. Medical history of ethanol consumption, laboratory markers of chronic ethanol intake, AST\/ALT ratio on the one hand and features of the metabolic syndrome on the other hand, may help in estimating the contribution of alcohol intake and the metabolic syndrome, respectively, to liver steatosis.<\/jats:p>","DOI":"10.3390\/ijms232416226","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T01:36:02Z","timestamp":1671500162000},"page":"16226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-8313","authenticated-orcid":false,"given":"Stephen D. H.","family":"Malnick","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kaplan Medical Center, Affiliated to Hebrew University, Rehovot 76100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Alin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaplan Medical Center, Affiliated to Hebrew University, Rehovot 76100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Somin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaplan Medical Center, Affiliated to Hebrew University, Rehovot 76100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela G.","family":"Neuman","sequence":"additional","affiliation":[{"name":"In Vitro Drug Safety and Biotechnology, Department of Pharmacology and Toxicology, Temerity Faculty of Medicine, University of Toronto, Toronto, ON M5G OA3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1054-3589(08)61001-7","article-title":"Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases","volume":"38","author":"Lieber","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"ref_2","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kumarendran, B., O\u2019Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W., and Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002542"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1570163817666200121143959","article-title":"Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development","volume":"18","author":"Thapa","year":"2021","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0046-8177(89)90249-9","article-title":"Nonalcoholic steatohepatitis: A study of 49 patients","volume":"20","author":"Lee","year":"1989","journal-title":"Hum. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0016-5085(88)90183-7","article-title":"Alcohol like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury","volume":"95","author":"Diehl","year":"1988","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0261-5614(99)80015-6","article-title":"Non-alcoholic fatty liver: Another feature of the metabolic syndrome?","volume":"18","author":"Camilo","year":"1999","journal-title":"Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: An expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1381\/096089206778663715","article-title":"The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women","volume":"16","author":"Arun","year":"2006","journal-title":"Obes. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2019.2276","article-title":"Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001\u20132016","volume":"321","author":"Wong","year":"2019","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2014.12.005","article-title":"Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort study","volume":"62","author":"Askgaard","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s13679-014-0129-4","article-title":"Alcohol Consumption and Obesity: An Update","volume":"4","author":"Traversy","year":"2015","journal-title":"Curr. Obes. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/00365521.2013.777469","article-title":"Smoking and risk of liver cirrhosis: A population-based cohort study","volume":"48","author":"Dam","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.1975.tb19146.x","article-title":"Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse","volume":"252","author":"Lelbach","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-991513","article-title":"Endoplasmic reticulum stress and liver injury","volume":"27","author":"Kaplowitz","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13690","DOI":"10.1038\/s41598-021-93086-y","article-title":"Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption","volume":"11","author":"Shiba","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199001113220205","article-title":"High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism","volume":"322","author":"Frezza","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1530-0277.1994.tb00042.x","article-title":"Effects of Helicobacter pylori infection and gastritis on gastric alcohol dehydrogenase activity","volume":"18","author":"Thuluvath","year":"1994","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/bj1190511","article-title":"Biochemical aspects associated with an ethanol-induced fatty liver","volume":"119","author":"Walker","year":"1970","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29342","DOI":"10.1074\/jbc.M202411200","article-title":"Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)","volume":"277","author":"You","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.cgh.2020.08.054","article-title":"Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population","volume":"19","author":"Lazo","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fimmu.2019.01328","article-title":"Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_35","first-page":"41","article-title":"Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration","volume":"18","author":"Sheron","year":"1993","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jhep.2019.12.017","article-title":"IL-33\/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis","volume":"72","author":"Artru","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_37","first-page":"141420","article-title":"Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis","volume":"6","author":"Poulsen","year":"2021","journal-title":"JCI Insight"},{"key":"ref_38","first-page":"537","article-title":"Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation","volume":"70","author":"Parkkila","year":"1994","journal-title":"Lab. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: Correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"180S","DOI":"10.1097\/01.alc.0000189276.34230.f5","article-title":"Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease","volume":"29","author":"McClain","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2019.12.016","article-title":"IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease","volume":"72","author":"Ma","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.510260622","article-title":"Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat","volume":"26","author":"Nanji","year":"1997","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1074\/jbc.M610602200","article-title":"Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1\/2 activity via 4-hydroxynonenal","volume":"282","author":"Sampey","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2741\/2138","article-title":"Mitochondrial function in liver disease","volume":"12","author":"Sastre","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2015-311314","article-title":"Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation","volume":"65","author":"Blaya","year":"2016","journal-title":"Gut"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"767584","DOI":"10.3389\/fmed.2021.767584","article-title":"Integrated Analyses Identify Key Molecules and Reveal the Potential Mechanism of miR-182-5p\/FOXO1 Axis in Alcoholic Liver Disease","volume":"8","author":"Zuo","year":"2021","journal-title":"Front. Med."},{"key":"ref_50","first-page":"7","article-title":"Alcohol congeners and their implications for medicolegal assessment of drunkeness","volume":"60","author":"Straka","year":"2015","journal-title":"Soud. Lek."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2016.04.023","article-title":"Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis","volume":"8","author":"Roerecke","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.dld.2009.03.005","article-title":"Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G\/C polymorphism is associated with non-alcoholic steatohepatitis","volume":"41","author":"Carulli","year":"2009","journal-title":"Dig. Liver Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23927","article-title":"Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 promoter","volume":"52","author":"Sookoian","year":"2010","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.gene.2013.06.091","article-title":"Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients","volume":"529","author":"Domenici","year":"2013","journal-title":"Gene"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jpeds.2010.11.016","article-title":"A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children","volume":"158","author":"Lin","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: A key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"Milner","year":"2008","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.23250","article-title":"Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice","volume":"51","author":"Fiorentino","year":"2010","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.21688","article-title":"A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis","volume":"46","author":"Calvert","year":"2007","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0026-0495(77)90020-8","article-title":"Hepatic lipid metabolism in severe human obesity","volume":"26","author":"Kral","year":"1977","journal-title":"Metabolism"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI111133","article-title":"Effect of fatty acids on glucose production and utilization in man","volume":"72","author":"Ferrannini","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/jhep.2003.50290","article-title":"Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis","volume":"38","author":"Sreekumar","year":"2003","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MEG.0b013e32831bc3d6","article-title":"Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"21","author":"Tajiri","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.25559","article-title":"Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease","volume":"55","author":"Guy","year":"2012","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/gutjnl-2014-307362","article-title":"Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis","volume":"64","author":"Machado","year":"2015","journal-title":"Gut"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0016-5085(98)70482-2","article-title":"Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis","volume":"114","author":"George","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0741-8329(03)00128-9","article-title":"Hemochromatosis and alcoholic liver disease","volume":"30","author":"Fletcher","year":"2003","journal-title":"Alcohol"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0016-5085(99)70401-4","article-title":"Insulin resistance-associated hepatic iron overload","volume":"117","author":"Mendler","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(99)80032-4","article-title":"Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis","volume":"31","author":"Bonkovsky","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/jhep.2002.33892","article-title":"HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.510300407","article-title":"Hepatic iron and nonalcoholic fatty liver disease","volume":"30","author":"Younossi","year":"1999","journal-title":"Hepatology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.27662","article-title":"The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial","volume":"61","author":"Adams","year":"2015","journal-title":"Hepatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0016-5085(00)70193-4","article-title":"Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes","volume":"118","author":"Vergani","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.02288","article-title":"Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease","volume":"155","author":"Nobili","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","article-title":"Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease","volume":"42","author":"Musso","year":"2005","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI200421270","article-title":"Role of resistin in diet-induced hepatic insulin resistance","volume":"114","author":"Muse","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"The Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486, 207\u2013214.","DOI":"10.1038\/nature11234"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4254\/wjh.v7.i12.1679","article-title":"Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease","volume":"7","author":"Abdallah","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: A fundamental role in health and disease","volume":"11","author":"Vancamelbeke","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","article-title":"Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: Reevaluation with an improved chromogenic assay","volume":"12","author":"Fukui","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(87)80003-X","article-title":"Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess","volume":"4","author":"Bode","year":"1987","journal-title":"J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","article-title":"Endotoxemia in patients with chronic liver diseases: Relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation","volume":"22","author":"Lin","year":"1995","journal-title":"J. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","article-title":"Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: Summary of a symposium","volume":"42","author":"Purohit","year":"2008","journal-title":"Alcohol"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-immunol-093019-112348","article-title":"Control of Immunity by the Microbiota","volume":"39","author":"Ansaldo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF02282340","article-title":"Small bowel bacterial overgrowth in patients with alcoholic cirrhosis","volume":"41","author":"Ledesma","year":"1996","journal-title":"Dig. Dis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.29623","article-title":"The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Couch, R.D., Dailey, A., Zaidi, F., Navarro, K., Forsyth, C.B., Mutlu, E., Engen, P.A., and Keshavarzian, A. (2015). Alcohol induced alterations to the human fecal VOC metabolome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119362"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Llopis","year":"2013","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Chiu, C.C., Ching, Y.H., Li, Y.P., Liu, J.-Y., Huang, Y.-T., Huang, Y.-W., Yang, S.-S., Huang, W.-C., and Chuang, H.-L. (2017). Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Nutrients, 9.","DOI":"10.3390\/nu9111220"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2016.00047","article-title":"Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions","volume":"7","author":"Elshaghabee","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/HMER.S254195","article-title":"Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet","volume":"12","author":"Elshaghabee","year":"2020","journal-title":"Hepatic Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ajcn\/28.11.1277","article-title":"Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity","volume":"28","author":"Mezey","year":"1975","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(86)90081-8","article-title":"Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats","volume":"90","author":"Baraona","year":"1986","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1572-0241.2001.03702.x","article-title":"Obesity and female gender increase breath ethanol concentration: Potential implications for the pathogenesis of nonalcoholic steatohepatitis","volume":"96","author":"Nair","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Sookoian, S., and Pirola, C.J. (2013). Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058895"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41575-020-0341-5","article-title":"Brain\u2013gut\u2013microbiome interactions in obesity and food addiction","volume":"17","author":"Gupta","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2021.12.035","article-title":"A disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Mehacagel","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Malnick, S.D.H., Fisher, D., Somin, M., and Neuman, M.G. (2021). Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. Biology, 10.","DOI":"10.3390\/biology10050447"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and Non-Alcoholic Fatty Liver Disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nier, A., Huber, Y., Labenz, C., Michel, M., Bergheim, I., and Schattenberg, J.M. (2020). Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12030699"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/carcin\/bgi337","article-title":"Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women","volume":"27","author":"Lee","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"15756","DOI":"10.1038\/s41598-017-15943-z","article-title":"PNPLA3 variant and portal\/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: A possible role for oxidative stress","volume":"7","author":"Carpino","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1617805","DOI":"10.1155\/2020\/1617805","article-title":"Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Nasc\u00e8, A., Gariani, K., Jornayvaz, F.R., and Szanto, I. (2022). NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants, 11.","DOI":"10.3390\/antiox11061131"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.bbagen.2016.09.009","article-title":"Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function","volume":"1861 Pt A","author":"Sun","year":"2017","journal-title":"Biochim. Et Biophys. Acta Gen. Subj."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"Heard","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/13543784.2018.1501471","article-title":"N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research","volume":"27","author":"Morley","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.freeradbiomed.2005.04.011","article-title":"Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition","volume":"39","author":"Ronis","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Yang, Y.M., Cho, Y.E., and Hwang, S. (2022). Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease. IJMS, 23.","DOI":"10.3390\/ijms23020774"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1360-0443.2005.01216.x","article-title":"Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: A study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin","volume":"100","author":"Hock","year":"2005","journal-title":"Addiction"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-8329(02)00204-5","article-title":"Liver disease in alcohol abusers: Clinical perspective","volume":"27","author":"Diehl","year":"2002","journal-title":"Alcohol"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1665-2681(19)32036-8","article-title":"Nonalcoholic steatohepatitis (NASH) with diabetes: Predictors of liver fibrosis","volume":"5","author":"Amarapurka","year":"2006","journal-title":"Ann. Hepatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease","volume":"94","author":"Sorbi","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/alcalc\/agh074","article-title":"High AST\/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking","volume":"39","author":"Nyblom","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF01324898","article-title":"The SGOT\/SGPT ratio\u2014An indicator of alcoholic liver disease","volume":"24","author":"Cohen","year":"1979","journal-title":"Dig. Dis. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01347885","article-title":"Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease","volume":"30","author":"Moussavian","year":"1985","journal-title":"Dig. Dis. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"678118","DOI":"10.3389\/fphys.2021.678118","article-title":"Non-invasive Biomarkers of Liver Inflammation and Cell Death in Response to Alcohol Detoxification","volume":"12","author":"Neuman","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"20170959","DOI":"10.1259\/bjr.20170959","article-title":"Liver fat imaging a clinical overview of ultrasound, CT, and MR imaging","volume":"91","author":"Zhang","year":"2018","journal-title":"Br. J. Radiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1381\/096089204323093408","article-title":"The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients","volume":"14","author":"Mottin","year":"2004","journal-title":"Obes. Surg."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0887-2171(95)90012-8","article-title":"CT and MRI of diffuse liver disease","volume":"16","author":"Rofsky","year":"1995","journal-title":"Semin. Ultrasound CT MR"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3748\/wjg.v16.i13.1560","article-title":"Liver fat content determined by magnetic resonance imaging and spectroscopy","volume":"16","author":"Springer","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: Echocardiographic and tissue Doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Minhas, A.M.K., Bhopalwala, H.M., Dewaswala, N., Salah, H.M., Khan, M.S., Shahid, I., Biegus, J., Lopes, R.D., Pandey, A., and Fudim, M. (2022). Association of Non-Alcoholic Fatty Liver Disease with In-Hospital Outcomes in Primary Heart Failure Hospitalizations with Reduced or Preserved Ejection Fraction. Curr. Probl. Cardiol., 101199.","DOI":"10.1016\/j.cpcardiol.2022.101199"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM196804182781602","article-title":"Alcohol-induced hepatic injury in nonalcoholic volunteers","volume":"278","author":"Rubin","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2004.11.001","article-title":"Morphology of alcoholic liver disease","volume":"9","author":"Lefkowitch","year":"2005","journal-title":"Clin. Liver Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2007-1007346","article-title":"Pathology of alcoholic liver disease. VA Cooperative Study Group 119","volume":"13","author":"French","year":"1993","journal-title":"Semin. Liver Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","article-title":"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver","volume":"346","author":"Teli","year":"1995","journal-title":"Lancet"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0009-9120(99)00058-2","article-title":"Novel morphologic findings in alcoholic liver disease","volume":"32","author":"Cameron","year":"1999","journal-title":"Clin. Biochem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1309\/WWNE-KW2C-4KTW-PTJ5","article-title":"Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients","volume":"116","author":"Turlin","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic Fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research","volume":"32","author":"Kleiner","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3748\/wjg.v16.i42.5286","article-title":"Histopathology of nonalcoholic fatty liver disease","volume":"16","author":"Brunt","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","article-title":"Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease","volume":"16","author":"Brunt","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward More Accurate Nomenclature for Fatty Liver Diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"Puukka","year":"2018","journal-title":"Hepatology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cgh.2018.01.026","article-title":"Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis","volume":"16","author":"Ajmera","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cgh.2019.05.004","article-title":"Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases","volume":"18","author":"Chang","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","article-title":"Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study","volume":"114","author":"Chang","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: Evidence from the Kangbuk Samsung Health Study","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000326854","article-title":"Carotid Intima-Media Thickness Is Increased Not Only in Non-Alcoholic Fatty Liver Disease Patients but Also in Alcoholic Fatty Liver Patients","volume":"84","author":"Kim","year":"2011","journal-title":"Digestion"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Maor, Y., Ergaz, D., Malnick, S.D.H., Melzer, E., and Neuman, M.G. (2021). Liraglutide-Induced Hepatotoxicity. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020106"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/cimb44030087","article-title":"Cellular, molecular, vial and clnical featues of alcohol and non-alcohol induced liver disease","volume":"44","author":"Neuman","year":"2022","journal-title":"Curr. Issue Mol. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0041-1729971","article-title":"Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations","volume":"41","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"G\u0142uszy\u0144ska, P., Lemancewicz, D., Dzi\u0119cio\u0142, J.B., and Razak Hady, H. (2021). Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric\/Metabolic Surgery as Its Treatment Option: A Review. JCM, 10.","DOI":"10.3390\/jcm10245721"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Friedman","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"von Loeffelholz, C., Roth, J., Coldewey, S., and Birkenfeld, A. (2021). The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121853"},{"key":"ref_180","first-page":"1445","article-title":"Long-term (\u22652 y) efficacy of vitamin E for non-alcoholic steatohepatitis","volume":"60","author":"Sumida","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile Acids and FXR: Novel Targets for Liver Diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front. Med."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T., and Rodrigues, R.M. (2019). Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. Cells, 9.","DOI":"10.3390\/cells9010037"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13543784.2020.1668375","article-title":"Elafibranor: A potential drug for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Drenth","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.cgh.2020.10.051","article-title":"A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis","volume":"19","author":"Siddiqui","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"106170","DOI":"10.1016\/j.cct.2020.106170","article-title":"A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study","volume":"98","author":"Sven","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed. Rep."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Armstrong","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc18-1569","article-title":"The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients","volume":"42","author":"Honka","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Filipovic, B., Lukic, S., Mijac, D., Marjanovic-Haljilji, M., Vojnovic, M., Bogdanovic, J., Glisic, T., Filipovic, N., Al Kiswani, J., and Djokovic, A. (2021). The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. IJMS, 22.","DOI":"10.3390\/ijms222413219"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"jcs237388","DOI":"10.1242\/jcs.237388","article-title":"ORP3 phosphorylation regulates phosphatidylinositol 4-phosphate and Ca2+ dynamics at plasma membrane-ER contact sites","volume":"133","author":"Sohn","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"jcs238394","DOI":"10.1242\/jcs.238394","article-title":"Bone marrow adipose cells\u2014Cellular interactions and changes with obesity","volume":"133","author":"Boroumand","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1017\/S0029665111000565","article-title":"Fats, inflammation and insulin resistance: Insights to the role of macrophage and T-cell accumulation in adipose tissue","volume":"70","author":"Harford","year":"2011","journal-title":"Proc. Nutr. Soc."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Tarantino, G., Citro, V., Balsano, C., and Capone, D. (2020). Could SCGF-Beta Levels Be Associated with Inflammation Markers and Insulin Resistance in Male Patients Suffering from Obesity-Related NAFLD?. Diagnostics, 10.","DOI":"10.3390\/diagnostics10060395"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1478-3231.2010.02287.x","article-title":"High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding","volume":"30","author":"Muntaner","year":"2010","journal-title":"Liver Int."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01893087","article-title":"Focal fatty liver lesions in alcoholic liver disease: A broadened spectrum of CT appearances","volume":"10","author":"Vas","year":"1985","journal-title":"Gastrointest. Radiol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic Liver Disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coph.2021.06.011","article-title":"Treatment of severe alcoholic hepatitis: A systematic review","volume":"60","author":"Korf","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e14522","DOI":"10.1111\/dme.14522","article-title":"Association of liver enzymes with incident diabetes in US Hispanic\/Latino adults","volume":"38","author":"Hua","year":"2021","journal-title":"Diabet. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3138\/canlivj-2021-0025","article-title":"Non-alcoholic fatty liver disease (NAFLD) in Filipino North American patients: Results from a multi-ethnic cohort","volume":"5","author":"Jiang","year":"2022","journal-title":"Can. Liver J."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Chen, K., Sng, W.K., Quah, J.H., Liu, J., Chong, B.Y., Lee, H.K., Wang, X.F., Tan, N.C., Chang, P.E., and Tan, H.C. (2020). Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236977"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: What we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jimd.12011","article-title":"Choline-related-inherited metabolic diseases\u2014A mini review","volume":"42","author":"Wortmann","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cob.12068","article-title":"Non-alcoholic fatty liver disease in obese adults: Clinical aspects and current management strategies","volume":"4","author":"Pallayova","year":"2014","journal-title":"Clin. Obes."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","article-title":"Global multi-stakeholder consensus on the redefinition of fatty liver disease. Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"Bugianesi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_212","first-page":"147","article-title":"Non-alcoholic fatty liver disease: An update on diagnosis","volume":"91","author":"Neuman","year":"2018","journal-title":"Clujul Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"104750","DOI":"10.1016\/j.yexmp.2022.104750","article-title":"Alcohol: Basic and translational research 15th annual Charles Lieber &1st Samuel French satellite symposium","volume":"126","author":"Neuman","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Teschke, R., Eickhoff, A., Brown, A.C., Neuman, M.G., and Schulze, J. (2019). Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010212"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ajcn\/86.2.276","article-title":"Low-carbohydrate nutrition and metabolism","volume":"86","author":"Westman","year":"2007","journal-title":"Am. J. Clin. Nutr."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/16226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:22Z","timestamp":1760147062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/16226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":215,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232416226"],"URL":"https:\/\/doi.org\/10.3390\/ijms232416226","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]}}}